US 7439226
Serine protease inhibitors
granted A61KA61K38/00
Quick answer
US patent 7439226 (Serine protease inhibitors) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00